Trulicity

Chemical Namedulaglutide
Dosage FormInjection (subcutaneous; 0.75 mg/0.5 mL, 1.5 mg/0.5 mL)
Drug ClassReceptor agonists
SystemEndocrine
CompanyEli Lilly and Company
Approval Year2014

Indication

  • An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Last updated on 4/19/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Trulicity (dulaglutide) Prescribing Information2014Eli Lilly and Company, Indianapolis, IN